Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transcranial Magnetic Stimulation | 171 | 2024 | 1472 | 18.870 |
Why?
|
Motor Cortex | 83 | 2024 | 1006 | 14.580 |
Why?
|
Electric Stimulation Therapy | 83 | 2024 | 628 | 13.290 |
Why?
|
Fibromyalgia | 35 | 2024 | 403 | 11.690 |
Why?
|
Phantom Limb | 17 | 2024 | 98 | 9.360 |
Why?
|
Prefrontal Cortex | 78 | 2024 | 2218 | 5.780 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 17 | 2024 | 170 | 5.360 |
Why?
|
Vagus Nerve Stimulation | 11 | 2024 | 227 | 5.280 |
Why?
|
Evoked Potentials, Motor | 37 | 2024 | 464 | 4.800 |
Why?
|
Pain Threshold | 32 | 2024 | 603 | 4.780 |
Why?
|
Electric Stimulation | 49 | 2023 | 1736 | 4.590 |
Why?
|
Spinal Cord Injuries | 22 | 2024 | 925 | 4.540 |
Why?
|
Neuralgia | 24 | 2024 | 614 | 4.520 |
Why?
|
Neuronal Plasticity | 39 | 2024 | 1435 | 4.270 |
Why?
|
Electroencephalography | 45 | 2024 | 6224 | 3.790 |
Why?
|
Pain Measurement | 59 | 2024 | 3550 | 3.680 |
Why?
|
Osteoarthritis, Knee | 12 | 2023 | 1229 | 3.340 |
Why?
|
Depressive Disorder, Major | 46 | 2024 | 4760 | 3.330 |
Why?
|
Exercise Therapy | 18 | 2024 | 928 | 3.080 |
Why?
|
Double-Blind Method | 101 | 2024 | 12330 | 2.950 |
Why?
|
Stroke | 49 | 2024 | 9756 | 2.520 |
Why?
|
Brain | 77 | 2024 | 27107 | 2.490 |
Why?
|
Pain | 42 | 2024 | 5071 | 2.470 |
Why?
|
Sertraline | 10 | 2016 | 209 | 2.360 |
Why?
|
Pain Perception | 8 | 2022 | 196 | 2.320 |
Why?
|
Cerebral Cortex | 36 | 2018 | 5776 | 2.240 |
Why?
|
Brain-Derived Neurotrophic Factor | 26 | 2023 | 602 | 2.230 |
Why?
|
Theta Rhythm | 4 | 2024 | 219 | 2.100 |
Why?
|
Functional Laterality | 33 | 2020 | 2256 | 1.990 |
Why?
|
Pyramidal Tracts | 11 | 2019 | 252 | 1.940 |
Why?
|
Humans | 502 | 2024 | 761423 | 1.780 |
Why?
|
Beta Rhythm | 4 | 2022 | 64 | 1.760 |
Why?
|
Deep Brain Stimulation | 16 | 2014 | 832 | 1.580 |
Why?
|
Depression | 27 | 2024 | 8122 | 1.560 |
Why?
|
Analgesia | 9 | 2023 | 461 | 1.540 |
Why?
|
Adult | 223 | 2024 | 221148 | 1.520 |
Why?
|
Male | 290 | 2024 | 360736 | 1.470 |
Why?
|
Models, Neurological | 15 | 2021 | 1767 | 1.460 |
Why?
|
Postural Balance | 6 | 2024 | 621 | 1.450 |
Why?
|
Neural Inhibition | 9 | 2024 | 590 | 1.440 |
Why?
|
Motor Activity | 16 | 2024 | 2711 | 1.430 |
Why?
|
Female | 288 | 2024 | 392581 | 1.410 |
Why?
|
Dominance, Cerebral | 10 | 2010 | 623 | 1.360 |
Why?
|
Hyperalgesia | 11 | 2020 | 531 | 1.350 |
Why?
|
Recovery of Function | 23 | 2024 | 2977 | 1.340 |
Why?
|
Middle Aged | 186 | 2024 | 220826 | 1.330 |
Why?
|
Cross-Over Studies | 27 | 2024 | 2076 | 1.330 |
Why?
|
Treatment Outcome | 122 | 2024 | 64651 | 1.300 |
Why?
|
Combined Modality Therapy | 32 | 2024 | 8529 | 1.230 |
Why?
|
Cognition | 30 | 2024 | 6986 | 1.220 |
Why?
|
Parkinson Disease | 16 | 2023 | 2877 | 1.220 |
Why?
|
Attention | 15 | 2021 | 2395 | 1.210 |
Why?
|
Fluoxetine | 6 | 2019 | 733 | 1.210 |
Why?
|
Cerebral Palsy | 9 | 2016 | 474 | 1.180 |
Why?
|
Autonomic Nervous System | 4 | 2024 | 701 | 1.170 |
Why?
|
Burns | 6 | 2020 | 1882 | 1.140 |
Why?
|
Electrodes | 14 | 2020 | 615 | 1.110 |
Why?
|
Psychomotor Performance | 18 | 2023 | 1879 | 1.110 |
Why?
|
Cross-Sectional Studies | 38 | 2024 | 26112 | 1.090 |
Why?
|
Motor Skills | 12 | 2019 | 520 | 1.080 |
Why?
|
Alpha Rhythm | 4 | 2024 | 110 | 1.080 |
Why?
|
Electroconvulsive Therapy | 7 | 2010 | 500 | 1.070 |
Why?
|
Patient Dropouts | 2 | 2019 | 412 | 1.070 |
Why?
|
Clinical Trials as Topic | 12 | 2019 | 8000 | 1.060 |
Why?
|
Brain Waves | 5 | 2021 | 408 | 1.050 |
Why?
|
Randomized Controlled Trials as Topic | 22 | 2024 | 10203 | 1.050 |
Why?
|
Somatosensory Cortex | 5 | 2020 | 512 | 1.020 |
Why?
|
Quality of Life | 20 | 2024 | 13361 | 1.010 |
Why?
|
Memory, Short-Term | 12 | 2018 | 982 | 1.010 |
Why?
|
Antidepressive Agents | 14 | 2024 | 2897 | 1.000 |
Why?
|
Young Adult | 84 | 2024 | 59207 | 0.970 |
Why?
|
Brain Mapping | 21 | 2024 | 6626 | 0.970 |
Why?
|
Epilepsy | 12 | 2016 | 3290 | 0.960 |
Why?
|
Hand | 13 | 2021 | 902 | 0.960 |
Why?
|
Peripheral Nerves | 3 | 2020 | 479 | 0.950 |
Why?
|
Amylases | 2 | 2015 | 170 | 0.950 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2023 | 1081 | 0.930 |
Why?
|
Affect | 14 | 2015 | 1485 | 0.900 |
Why?
|
Neuropsychological Tests | 33 | 2024 | 7045 | 0.900 |
Why?
|
Memory Disorders | 5 | 2024 | 1198 | 0.870 |
Why?
|
Aged | 106 | 2024 | 169235 | 0.840 |
Why?
|
Brazil | 17 | 2024 | 1230 | 0.830 |
Why?
|
Depressive Disorder | 9 | 2023 | 3728 | 0.820 |
Why?
|
Brain Diseases | 4 | 2021 | 1545 | 0.820 |
Why?
|
Biomedical Research | 7 | 2014 | 3429 | 0.810 |
Why?
|
Lipase | 2 | 2015 | 325 | 0.810 |
Why?
|
Urinary Incontinence, Stress | 1 | 2024 | 181 | 0.790 |
Why?
|
Movement | 7 | 2014 | 1478 | 0.790 |
Why?
|
Analysis of Variance | 30 | 2017 | 6231 | 0.770 |
Why?
|
Cortical Synchronization | 3 | 2023 | 77 | 0.750 |
Why?
|
Paresis | 5 | 2019 | 176 | 0.740 |
Why?
|
Lower Extremity | 5 | 2024 | 1201 | 0.740 |
Why?
|
Rats, Wistar | 22 | 2023 | 1847 | 0.740 |
Why?
|
Upper Extremity | 8 | 2024 | 657 | 0.740 |
Why?
|
Reaction Time | 17 | 2017 | 2080 | 0.730 |
Why?
|
Motor Neurons | 3 | 2015 | 870 | 0.730 |
Why?
|
Evoked Potentials, Auditory | 2 | 2016 | 530 | 0.730 |
Why?
|
Imagination | 2 | 2015 | 226 | 0.730 |
Why?
|
Photic Stimulation | 18 | 2015 | 1985 | 0.720 |
Why?
|
Levodopa | 5 | 2016 | 221 | 0.720 |
Why?
|
Frontal Lobe | 6 | 2014 | 1420 | 0.710 |
Why?
|
Nervous System Diseases | 4 | 2019 | 1666 | 0.700 |
Why?
|
Pain, Intractable | 1 | 2021 | 132 | 0.680 |
Why?
|
Pruritus | 3 | 2019 | 380 | 0.680 |
Why?
|
Muscle, Skeletal | 6 | 2024 | 4946 | 0.670 |
Why?
|
Emotions | 8 | 2024 | 2739 | 0.670 |
Why?
|
Amputees | 4 | 2021 | 91 | 0.670 |
Why?
|
Pelvic Pain | 2 | 2014 | 298 | 0.660 |
Why?
|
Aphasia | 5 | 2017 | 192 | 0.660 |
Why?
|
Gait | 4 | 2020 | 816 | 0.650 |
Why?
|
Heart Rate | 11 | 2024 | 4198 | 0.650 |
Why?
|
Fatigue | 6 | 2024 | 1551 | 0.640 |
Why?
|
Skull | 5 | 2012 | 818 | 0.630 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 277 | 0.630 |
Why?
|
Learning | 11 | 2018 | 1740 | 0.620 |
Why?
|
Antidepressive Agents, Second-Generation | 4 | 2017 | 489 | 0.620 |
Why?
|
Rehabilitation | 2 | 2010 | 130 | 0.620 |
Why?
|
Myofascial Pain Syndromes | 6 | 2016 | 37 | 0.610 |
Why?
|
Pilot Projects | 18 | 2022 | 8633 | 0.610 |
Why?
|
Placebo Effect | 7 | 2020 | 518 | 0.610 |
Why?
|
Persistent Vegetative State | 4 | 2023 | 273 | 0.610 |
Why?
|
Thiopental | 2 | 2008 | 55 | 0.590 |
Why?
|
Anxiety | 13 | 2024 | 4572 | 0.590 |
Why?
|
Low Back Pain | 3 | 2022 | 984 | 0.590 |
Why?
|
Arthralgia | 1 | 2022 | 461 | 0.590 |
Why?
|
Sensation | 4 | 2021 | 337 | 0.590 |
Why?
|
Catastrophization | 5 | 2024 | 348 | 0.590 |
Why?
|
Pancreatitis | 2 | 2015 | 1096 | 0.580 |
Why?
|
Problem Solving | 3 | 2016 | 441 | 0.570 |
Why?
|
Robotics | 8 | 2021 | 819 | 0.560 |
Why?
|
Magnetics | 7 | 2005 | 599 | 0.560 |
Why?
|
Activities of Daily Living | 5 | 2024 | 2421 | 0.560 |
Why?
|
Diabetic Neuropathies | 1 | 2020 | 405 | 0.550 |
Why?
|
Publications | 1 | 2019 | 194 | 0.550 |
Why?
|
Decision Making | 8 | 2014 | 3929 | 0.550 |
Why?
|
Psychiatric Status Rating Scales | 21 | 2017 | 6019 | 0.540 |
Why?
|
Mental Disorders | 10 | 2021 | 6841 | 0.530 |
Why?
|
Cortical Spreading Depression | 4 | 2012 | 288 | 0.530 |
Why?
|
Galvanic Skin Response | 2 | 2016 | 357 | 0.530 |
Why?
|
Pancreatitis, Chronic | 2 | 2010 | 289 | 0.520 |
Why?
|
Corpus Callosum | 3 | 2018 | 751 | 0.520 |
Why?
|
Seizures | 6 | 2020 | 2957 | 0.510 |
Why?
|
Language Disorders | 2 | 2013 | 140 | 0.510 |
Why?
|
Research Design | 10 | 2017 | 6178 | 0.510 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2014 | 3769 | 0.510 |
Why?
|
Publishing | 2 | 2013 | 833 | 0.500 |
Why?
|
Cues | 7 | 2014 | 875 | 0.500 |
Why?
|
Cognition Disorders | 9 | 2013 | 3979 | 0.500 |
Why?
|
Adolescent | 58 | 2024 | 88313 | 0.500 |
Why?
|
Etomidate | 2 | 2008 | 185 | 0.500 |
Why?
|
Motor Skills Disorders | 2 | 2013 | 89 | 0.500 |
Why?
|
Chronic Disease | 24 | 2019 | 9320 | 0.500 |
Why?
|
Risk-Taking | 4 | 2014 | 1037 | 0.490 |
Why?
|
Time Factors | 39 | 2024 | 39975 | 0.490 |
Why?
|
Vagus Nerve | 5 | 2024 | 458 | 0.490 |
Why?
|
Placebos | 6 | 2019 | 1667 | 0.490 |
Why?
|
Patient Participation | 1 | 2024 | 1444 | 0.480 |
Why?
|
Ketamine | 1 | 2021 | 519 | 0.480 |
Why?
|
Electroencephalography Phase Synchronization | 1 | 2014 | 8 | 0.480 |
Why?
|
Computer Simulation | 11 | 2017 | 6238 | 0.470 |
Why?
|
Dopamine Agents | 2 | 2016 | 189 | 0.470 |
Why?
|
Evoked Potentials | 7 | 2024 | 1037 | 0.470 |
Why?
|
Homeostasis | 2 | 2024 | 3321 | 0.470 |
Why?
|
Parietal Lobe | 5 | 2013 | 851 | 0.460 |
Why?
|
Cerebellum | 4 | 2023 | 1500 | 0.450 |
Why?
|
Auditory Perception | 2 | 2016 | 583 | 0.450 |
Why?
|
Temporal Lobe | 6 | 2014 | 1695 | 0.450 |
Why?
|
Single-Blind Method | 9 | 2020 | 1571 | 0.450 |
Why?
|
Citalopram | 3 | 2017 | 402 | 0.450 |
Why?
|
Ataxia | 1 | 2016 | 306 | 0.450 |
Why?
|
Bipolar Disorder | 5 | 2017 | 5091 | 0.440 |
Why?
|
Patient Selection | 5 | 2024 | 4244 | 0.440 |
Why?
|
Rest | 3 | 2024 | 919 | 0.440 |
Why?
|
Hyperphagia | 2 | 2015 | 139 | 0.430 |
Why?
|
Severity of Illness Index | 18 | 2024 | 15838 | 0.430 |
Why?
|
Prader-Willi Syndrome | 2 | 2015 | 78 | 0.430 |
Why?
|
Electromyography | 8 | 2022 | 1393 | 0.430 |
Why?
|
Restraint, Physical | 4 | 2015 | 187 | 0.420 |
Why?
|
Electromagnetic Fields | 5 | 2010 | 296 | 0.420 |
Why?
|
Tinnitus | 4 | 2011 | 196 | 0.420 |
Why?
|
Sensation Disorders | 1 | 2014 | 160 | 0.420 |
Why?
|
Alcoholism | 4 | 2014 | 1973 | 0.420 |
Why?
|
Trigeminal Nerve | 1 | 2014 | 248 | 0.420 |
Why?
|
Analgesics | 7 | 2024 | 1070 | 0.410 |
Why?
|
Apathy | 1 | 2013 | 107 | 0.410 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2016 | 389 | 0.410 |
Why?
|
Mobility Limitation | 2 | 2015 | 408 | 0.410 |
Why?
|
Pain, Postoperative | 3 | 2023 | 1737 | 0.400 |
Why?
|
Latin America | 3 | 2023 | 410 | 0.400 |
Why?
|
Propofol | 2 | 2008 | 603 | 0.380 |
Why?
|
Movement Disorders | 2 | 2015 | 459 | 0.380 |
Why?
|
Hand Strength | 4 | 2024 | 456 | 0.380 |
Why?
|
Rats | 24 | 2023 | 23742 | 0.380 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2013 | 246 | 0.380 |
Why?
|
Sensory Thresholds | 3 | 2017 | 377 | 0.380 |
Why?
|
Magnetic Resonance Imaging | 29 | 2024 | 36423 | 0.370 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 605 | 0.370 |
Why?
|
Amantadine | 1 | 2011 | 57 | 0.370 |
Why?
|
Quadriplegia | 2 | 2015 | 226 | 0.370 |
Why?
|
Spectroscopy, Near-Infrared | 3 | 2024 | 740 | 0.370 |
Why?
|
Visual Perception | 6 | 2015 | 1385 | 0.360 |
Why?
|
Anesthesia, Intravenous | 2 | 2008 | 129 | 0.360 |
Why?
|
Memory | 8 | 2011 | 2187 | 0.350 |
Why?
|
Abdominal Pain | 2 | 2007 | 1071 | 0.350 |
Why?
|
Executive Function | 5 | 2024 | 1389 | 0.340 |
Why?
|
Running | 2 | 2024 | 488 | 0.340 |
Why?
|
Methylphenidate | 1 | 2014 | 488 | 0.340 |
Why?
|
Facial Pain | 2 | 2014 | 120 | 0.340 |
Why?
|
Tension-Type Headache | 3 | 2023 | 76 | 0.330 |
Why?
|
Nerve Net | 6 | 2024 | 2288 | 0.330 |
Why?
|
Antiparkinson Agents | 3 | 2006 | 184 | 0.330 |
Why?
|
Judgment | 2 | 2008 | 273 | 0.330 |
Why?
|
Alzheimer Disease | 5 | 2024 | 8596 | 0.330 |
Why?
|
MEDLINE | 4 | 2011 | 119 | 0.330 |
Why?
|
Exercise | 4 | 2024 | 5884 | 0.330 |
Why?
|
Physical Stimulation | 2 | 2010 | 517 | 0.320 |
Why?
|
Electric Conductivity | 1 | 2009 | 405 | 0.320 |
Why?
|
Forecasting | 4 | 2020 | 2928 | 0.320 |
Why?
|
Animals | 48 | 2024 | 168441 | 0.310 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7389 | 0.310 |
Why?
|
Meta-Analysis as Topic | 3 | 2021 | 1377 | 0.310 |
Why?
|
Arm | 4 | 2019 | 590 | 0.310 |
Why?
|
Trigeminal Neuralgia | 1 | 2009 | 107 | 0.310 |
Why?
|
Vulvar Diseases | 1 | 2008 | 64 | 0.310 |
Why?
|
Vestibular Diseases | 1 | 2011 | 230 | 0.300 |
Why?
|
Hippocampus | 4 | 2021 | 3763 | 0.300 |
Why?
|
Psychopharmacology | 1 | 2010 | 148 | 0.300 |
Why?
|
Migraine Disorders | 3 | 2023 | 1700 | 0.300 |
Why?
|
Disability Evaluation | 6 | 2017 | 1836 | 0.300 |
Why?
|
Pattern Recognition, Visual | 7 | 2012 | 820 | 0.300 |
Why?
|
Thalamus | 2 | 2011 | 1044 | 0.290 |
Why?
|
Evidence-Based Medicine | 5 | 2021 | 3687 | 0.290 |
Why?
|
Gait Disorders, Neurologic | 2 | 2024 | 240 | 0.290 |
Why?
|
Sample Size | 1 | 2011 | 840 | 0.290 |
Why?
|
Neurotransmitter Agents | 2 | 2010 | 665 | 0.290 |
Why?
|
Models, Biological | 5 | 2020 | 9469 | 0.290 |
Why?
|
Marijuana Smoking | 1 | 2010 | 258 | 0.280 |
Why?
|
Brain Injuries | 5 | 2014 | 2053 | 0.280 |
Why?
|
Bone Plates | 1 | 2010 | 465 | 0.280 |
Why?
|
Follow-Up Studies | 19 | 2019 | 39117 | 0.280 |
Why?
|
Encephalitis | 1 | 2010 | 438 | 0.280 |
Why?
|
Stress, Psychological | 3 | 2017 | 4477 | 0.280 |
Why?
|
Physical Conditioning, Animal | 2 | 2021 | 365 | 0.270 |
Why?
|
Video Games | 2 | 2023 | 198 | 0.270 |
Why?
|
Body Mass Index | 1 | 2024 | 12951 | 0.270 |
Why?
|
Spinal Cord | 7 | 2021 | 1818 | 0.270 |
Why?
|
Myoclonic Epilepsy, Juvenile | 1 | 2006 | 13 | 0.270 |
Why?
|
Interleukin-10 | 7 | 2023 | 1175 | 0.270 |
Why?
|
Gambling | 1 | 2010 | 258 | 0.260 |
Why?
|
Melatonin | 3 | 2020 | 669 | 0.260 |
Why?
|
Neural Pathways | 9 | 2021 | 3057 | 0.260 |
Why?
|
Education, Distance | 1 | 2010 | 260 | 0.260 |
Why?
|
Viscera | 1 | 2006 | 138 | 0.260 |
Why?
|
Electricity | 1 | 2006 | 181 | 0.250 |
Why?
|
Anticonvulsants | 3 | 2020 | 1906 | 0.250 |
Why?
|
Central Nervous System Stimulants | 1 | 2014 | 1176 | 0.250 |
Why?
|
Central Nervous System | 3 | 2015 | 1337 | 0.250 |
Why?
|
Research | 2 | 2011 | 1977 | 0.250 |
Why?
|
Paralysis | 1 | 2006 | 250 | 0.250 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2009 | 352 | 0.250 |
Why?
|
Internationality | 2 | 2011 | 1001 | 0.240 |
Why?
|
Crack Cocaine | 2 | 2015 | 32 | 0.240 |
Why?
|
Telemedicine | 1 | 2022 | 3051 | 0.240 |
Why?
|
Research Personnel | 1 | 2010 | 588 | 0.240 |
Why?
|
Finite Element Analysis | 5 | 2021 | 437 | 0.240 |
Why?
|
Diffusion of Innovation | 1 | 2010 | 728 | 0.240 |
Why?
|
Safety | 4 | 2017 | 1150 | 0.240 |
Why?
|
Facial Expression | 1 | 2008 | 508 | 0.240 |
Why?
|
Behavior | 4 | 2015 | 540 | 0.240 |
Why?
|
Feeding Behavior | 4 | 2024 | 3187 | 0.240 |
Why?
|
Databases, Bibliographic | 2 | 2018 | 130 | 0.230 |
Why?
|
Psychotropic Drugs | 3 | 2024 | 888 | 0.230 |
Why?
|
Spinal Osteophytosis | 1 | 2004 | 30 | 0.230 |
Why?
|
Food Preferences | 1 | 2007 | 398 | 0.230 |
Why?
|
Random Allocation | 5 | 2016 | 2394 | 0.230 |
Why?
|
Phrenic Nerve | 1 | 2004 | 79 | 0.220 |
Why?
|
Hemiplegia | 2 | 2016 | 136 | 0.220 |
Why?
|
Anesthetics, Intravenous | 1 | 2007 | 396 | 0.220 |
Why?
|
Muscle Fatigue | 1 | 2024 | 95 | 0.220 |
Why?
|
Verbal Behavior | 3 | 2012 | 335 | 0.220 |
Why?
|
Internet | 3 | 2010 | 3092 | 0.220 |
Why?
|
Opioid-Related Disorders | 1 | 2018 | 2162 | 0.220 |
Why?
|
Electrophysiological Phenomena | 2 | 2017 | 307 | 0.220 |
Why?
|
Therapy, Computer-Assisted | 2 | 2019 | 266 | 0.220 |
Why?
|
Wallerian Degeneration | 1 | 2003 | 68 | 0.220 |
Why?
|
Prospective Studies | 15 | 2024 | 54415 | 0.220 |
Why?
|
Occipital Lobe | 5 | 2008 | 374 | 0.220 |
Why?
|
Muscle Strength | 3 | 2020 | 624 | 0.220 |
Why?
|
Organ Transplantation | 1 | 2014 | 1157 | 0.220 |
Why?
|
Aged, 80 and over | 16 | 2024 | 58956 | 0.220 |
Why?
|
Subclavian Steal Syndrome | 1 | 2003 | 20 | 0.220 |
Why?
|
Survivors | 4 | 2022 | 2371 | 0.220 |
Why?
|
Valproic Acid | 1 | 2006 | 443 | 0.220 |
Why?
|
Peripheral Nervous System | 2 | 2019 | 151 | 0.210 |
Why?
|
Muscle Contraction | 2 | 2022 | 1201 | 0.210 |
Why?
|
Cohort Studies | 6 | 2024 | 41446 | 0.210 |
Why?
|
Substance-Related Disorders | 2 | 2019 | 4420 | 0.210 |
Why?
|
Sleep | 6 | 2023 | 4766 | 0.210 |
Why?
|
Anesthetics | 1 | 2008 | 523 | 0.210 |
Why?
|
Pelvic Floor | 1 | 2024 | 137 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3082 | 0.210 |
Why?
|
Home Care Services | 2 | 2020 | 648 | 0.210 |
Why?
|
Headache | 4 | 2023 | 1256 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3202 | 0.210 |
Why?
|
Feasibility Studies | 6 | 2019 | 5246 | 0.210 |
Why?
|
Deglutition Disorders | 1 | 2008 | 625 | 0.210 |
Why?
|
Subclavian Artery | 1 | 2003 | 134 | 0.200 |
Why?
|
Fires | 2 | 2014 | 170 | 0.200 |
Why?
|
Voice Disorders | 1 | 2006 | 286 | 0.200 |
Why?
|
Physical Endurance | 1 | 2024 | 366 | 0.200 |
Why?
|
Physical Therapy Modalities | 5 | 2023 | 532 | 0.200 |
Why?
|
Proprioception | 1 | 2023 | 133 | 0.200 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2011 | 1491 | 0.200 |
Why?
|
Analgesics, Opioid | 3 | 2024 | 3804 | 0.200 |
Why?
|
Spinal Cord Compression | 1 | 2004 | 235 | 0.190 |
Why?
|
Memory, Long-Term | 2 | 2021 | 59 | 0.190 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1886 | 0.190 |
Why?
|
Reference Values | 5 | 2016 | 4921 | 0.190 |
Why?
|
Postpartum Period | 1 | 2008 | 1173 | 0.190 |
Why?
|
Cocaine-Related Disorders | 2 | 2015 | 461 | 0.190 |
Why?
|
Hypnotics and Sedatives | 2 | 2012 | 1179 | 0.190 |
Why?
|
Dose-Response Relationship, Radiation | 4 | 2008 | 882 | 0.190 |
Why?
|
Models, Animal | 3 | 2023 | 2113 | 0.190 |
Why?
|
Neurology | 1 | 2009 | 780 | 0.180 |
Why?
|
Aspartic Acid | 3 | 2012 | 576 | 0.180 |
Why?
|
Language | 5 | 2013 | 1539 | 0.180 |
Why?
|
Resistance Training | 1 | 2023 | 193 | 0.180 |
Why?
|
Locomotion | 2 | 2021 | 388 | 0.180 |
Why?
|
Aphasia, Broca | 2 | 2011 | 52 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8641 | 0.180 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14599 | 0.170 |
Why?
|
Rabbits | 2 | 2017 | 4779 | 0.170 |
Why?
|
Hot Temperature | 4 | 2015 | 1440 | 0.170 |
Why?
|
Physician Impairment | 1 | 2020 | 72 | 0.170 |
Why?
|
Antipsychotic Agents | 2 | 2010 | 3068 | 0.170 |
Why?
|
Cardiovascular System | 1 | 2007 | 835 | 0.170 |
Why?
|
Orientation | 1 | 2021 | 321 | 0.160 |
Why?
|
General Surgery | 1 | 2011 | 1692 | 0.160 |
Why?
|
Cardiology | 1 | 2010 | 1667 | 0.160 |
Why?
|
Behavior, Animal | 2 | 2018 | 1878 | 0.160 |
Why?
|
Neurologic Examination | 4 | 2011 | 916 | 0.160 |
Why?
|
Angioplasty, Balloon | 1 | 2003 | 588 | 0.160 |
Why?
|
Teaching | 3 | 2015 | 1169 | 0.160 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2018 | 3704 | 0.160 |
Why?
|
Sjogren's Syndrome | 1 | 2020 | 234 | 0.160 |
Why?
|
Period Circadian Proteins | 1 | 2019 | 96 | 0.160 |
Why?
|
Asia | 1 | 2020 | 619 | 0.160 |
Why?
|
Consciousness Disorders | 2 | 2023 | 441 | 0.160 |
Why?
|
Knee Joint | 2 | 2021 | 1673 | 0.160 |
Why?
|
Minisatellite Repeats | 1 | 2019 | 164 | 0.160 |
Why?
|
Child | 17 | 2021 | 80162 | 0.160 |
Why?
|
Mood Disorders | 2 | 2024 | 1127 | 0.150 |
Why?
|
Population Dynamics | 1 | 2020 | 307 | 0.150 |
Why?
|
Disease Models, Animal | 10 | 2021 | 18247 | 0.150 |
Why?
|
Africa | 1 | 2020 | 710 | 0.150 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1863 | 0.150 |
Why?
|
Pressure | 5 | 2014 | 1155 | 0.150 |
Why?
|
Hydrocortisone | 3 | 2022 | 1815 | 0.150 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2374 | 0.150 |
Why?
|
Sex Characteristics | 1 | 2008 | 2637 | 0.150 |
Why?
|
Halitosis | 1 | 2017 | 13 | 0.150 |
Why?
|
Urban Health | 1 | 2020 | 533 | 0.150 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2004 | 710 | 0.150 |
Why?
|
Diagnostic Equipment | 1 | 2017 | 11 | 0.150 |
Why?
|
Touch | 2 | 2012 | 313 | 0.140 |
Why?
|
Electroacupuncture | 2 | 2015 | 66 | 0.140 |
Why?
|
Neuroblastoma | 2 | 2023 | 1250 | 0.140 |
Why?
|
Research Subjects | 1 | 2019 | 249 | 0.140 |
Why?
|
Musculoskeletal Manipulations | 1 | 2017 | 24 | 0.140 |
Why?
|
Hallux Valgus | 1 | 2017 | 67 | 0.140 |
Why?
|
Knee Injuries | 2 | 2012 | 487 | 0.140 |
Why?
|
Cluster Analysis | 1 | 2024 | 2706 | 0.140 |
Why?
|
Diarrhea | 1 | 2004 | 1318 | 0.140 |
Why?
|
Multivariate Analysis | 4 | 2021 | 12058 | 0.140 |
Why?
|
Tears | 1 | 2018 | 251 | 0.140 |
Why?
|
Neurophysiology | 2 | 2008 | 144 | 0.140 |
Why?
|
Speech Therapy | 2 | 2015 | 57 | 0.140 |
Why?
|
Smoking | 2 | 2014 | 9052 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2021 | 4354 | 0.140 |
Why?
|
Hemianopsia | 2 | 2012 | 121 | 0.140 |
Why?
|
Epilepsia Partialis Continua | 1 | 2016 | 18 | 0.130 |
Why?
|
Ethics Committees | 1 | 2016 | 51 | 0.130 |
Why?
|
Behavior, Addictive | 2 | 2013 | 462 | 0.130 |
Why?
|
Walking | 2 | 2021 | 1200 | 0.130 |
Why?
|
Quality Control | 2 | 2010 | 832 | 0.130 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 2014 | 1068 | 0.130 |
Why?
|
Statistics, Nonparametric | 5 | 2013 | 2851 | 0.130 |
Why?
|
Authorship | 1 | 2019 | 284 | 0.130 |
Why?
|
Physical Examination | 1 | 2022 | 1254 | 0.130 |
Why?
|
Salivary Proteins and Peptides | 1 | 2016 | 48 | 0.130 |
Why?
|
Sclerosis | 1 | 2016 | 210 | 0.130 |
Why?
|
Smoking Cessation | 1 | 2008 | 2056 | 0.130 |
Why?
|
Quality-Adjusted Life Years | 1 | 2022 | 1722 | 0.130 |
Why?
|
Exploratory Behavior | 3 | 2016 | 279 | 0.130 |
Why?
|
Software | 1 | 2010 | 4434 | 0.130 |
Why?
|
Lidocaine | 2 | 2016 | 538 | 0.130 |
Why?
|
Glutamic Acid | 2 | 2012 | 1176 | 0.130 |
Why?
|
Nasal Mucosa | 1 | 2018 | 415 | 0.120 |
Why?
|
Acupuncture Analgesia | 1 | 2015 | 63 | 0.120 |
Why?
|
Electrodiagnosis | 1 | 2016 | 148 | 0.120 |
Why?
|
Injections, Spinal | 1 | 2016 | 318 | 0.120 |
Why?
|
Video Recording | 2 | 2019 | 966 | 0.120 |
Why?
|
Erythema | 1 | 2016 | 262 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2004 | 1230 | 0.120 |
Why?
|
Personality Inventory | 2 | 2008 | 1019 | 0.120 |
Why?
|
Paraplegia | 1 | 2015 | 162 | 0.120 |
Why?
|
Morbidity | 1 | 2020 | 1750 | 0.120 |
Why?
|
Schizophrenia | 5 | 2014 | 6937 | 0.120 |
Why?
|
Ethics Committees, Research | 1 | 2016 | 196 | 0.120 |
Why?
|
Hot Flashes | 1 | 2017 | 330 | 0.120 |
Why?
|
Disabled Persons | 1 | 2024 | 1225 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2010 | 1975 | 0.120 |
Why?
|
Periodicals as Topic | 2 | 2019 | 1463 | 0.120 |
Why?
|
Sciatic Nerve | 4 | 2020 | 616 | 0.120 |
Why?
|
Nursing Process | 1 | 2014 | 17 | 0.120 |
Why?
|
Dyspnea | 1 | 2022 | 1347 | 0.120 |
Why?
|
Interleukin-6 | 3 | 2023 | 3207 | 0.120 |
Why?
|
HTLV-I Infections | 1 | 2014 | 103 | 0.120 |
Why?
|
Clinical Protocols | 4 | 2017 | 1440 | 0.120 |
Why?
|
Cell Survival | 2 | 2023 | 5790 | 0.110 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 506 | 0.110 |
Why?
|
Dry Eye Syndromes | 1 | 2018 | 387 | 0.110 |
Why?
|
Amphetamine-Related Disorders | 1 | 2014 | 80 | 0.110 |
Why?
|
Regression Analysis | 2 | 2016 | 6343 | 0.110 |
Why?
|
Remission Induction | 2 | 2010 | 2395 | 0.110 |
Why?
|
Amputation Stumps | 1 | 2013 | 38 | 0.110 |
Why?
|
Schizophrenia, Catatonic | 1 | 2013 | 6 | 0.110 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2017 | 303 | 0.110 |
Why?
|
Thinking | 1 | 2016 | 320 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 642 | 0.110 |
Why?
|
Temporomandibular Joint Dysfunction Syndrome | 1 | 2012 | 24 | 0.110 |
Why?
|
Cytokines | 3 | 2018 | 7392 | 0.110 |
Why?
|
Risk Factors | 9 | 2022 | 74167 | 0.110 |
Why?
|
Action Potentials | 1 | 2020 | 1834 | 0.110 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2012 | 4579 | 0.100 |
Why?
|
Hallucinations | 2 | 2013 | 366 | 0.100 |
Why?
|
Cognitive Reserve | 1 | 2013 | 92 | 0.100 |
Why?
|
Demography | 3 | 2022 | 1648 | 0.100 |
Why?
|
Consensus | 1 | 2022 | 3122 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2021 | 1496 | 0.100 |
Why?
|
Neurosecretory Systems | 1 | 2014 | 223 | 0.100 |
Why?
|
Consciousness | 1 | 2018 | 601 | 0.100 |
Why?
|
Vitiligo | 1 | 2013 | 97 | 0.100 |
Why?
|
Serotonin | 2 | 2014 | 1042 | 0.100 |
Why?
|
Morale | 1 | 2011 | 13 | 0.100 |
Why?
|
Injury Severity Score | 1 | 2015 | 1045 | 0.100 |
Why?
|
Age Factors | 4 | 2024 | 18400 | 0.100 |
Why?
|
Task Performance and Analysis | 2 | 2017 | 761 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 495 | 0.100 |
Why?
|
Anesthetics, Local | 2 | 2016 | 997 | 0.100 |
Why?
|
Interpersonal Relations | 2 | 2011 | 1436 | 0.100 |
Why?
|
Educational Status | 2 | 2024 | 2520 | 0.100 |
Why?
|
Headache Disorders | 1 | 2014 | 152 | 0.100 |
Why?
|
Cerebrovascular Circulation | 3 | 2014 | 2727 | 0.100 |
Why?
|
Leukoaraiosis | 1 | 2012 | 116 | 0.100 |
Why?
|
Psychometrics | 2 | 2012 | 3065 | 0.100 |
Why?
|
Neostriatum | 1 | 2012 | 246 | 0.090 |
Why?
|
Interleukin-1beta | 4 | 2020 | 997 | 0.090 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 324 | 0.090 |
Why?
|
Employment | 1 | 2017 | 1118 | 0.090 |
Why?
|
Thyroid Hormones | 1 | 2014 | 404 | 0.090 |
Why?
|
Stents | 1 | 2003 | 3179 | 0.090 |
Why?
|
Cerebral Hemorrhage | 1 | 2022 | 2656 | 0.090 |
Why?
|
Afferent Pathways | 1 | 2012 | 298 | 0.090 |
Why?
|
Electrodes, Implanted | 3 | 2014 | 840 | 0.090 |
Why?
|
User-Computer Interface | 2 | 2017 | 1400 | 0.090 |
Why?
|
Feedback, Sensory | 1 | 2011 | 56 | 0.090 |
Why?
|
Tenodesis | 1 | 2011 | 50 | 0.090 |
Why?
|
Efferent Pathways | 1 | 2011 | 165 | 0.090 |
Why?
|
Vestibular Function Tests | 1 | 2011 | 128 | 0.090 |
Why?
|
Pain, Referred | 1 | 2010 | 5 | 0.090 |
Why?
|
Inflammation | 4 | 2023 | 10762 | 0.090 |
Why?
|
Friends | 1 | 2011 | 149 | 0.090 |
Why?
|
Neglected Diseases | 1 | 2011 | 66 | 0.090 |
Why?
|
Empathy | 1 | 2015 | 473 | 0.090 |
Why?
|
Musculoskeletal System | 1 | 2012 | 188 | 0.090 |
Why?
|
Models, Statistical | 2 | 2017 | 5077 | 0.090 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7825 | 0.090 |
Why?
|
Energy Intake | 2 | 2016 | 2134 | 0.090 |
Why?
|
Reproducibility of Results | 6 | 2017 | 20093 | 0.090 |
Why?
|
Drug Resistance | 2 | 2006 | 1595 | 0.090 |
Why?
|
Illusions | 1 | 2010 | 61 | 0.090 |
Why?
|
Lactation | 1 | 2012 | 397 | 0.090 |
Why?
|
Sunburn | 1 | 2010 | 156 | 0.080 |
Why?
|
Mental Recall | 1 | 2016 | 1214 | 0.080 |
Why?
|
Food | 1 | 2014 | 772 | 0.080 |
Why?
|
Femur | 2 | 2012 | 1307 | 0.080 |
Why?
|
Epidemiologic Research Design | 1 | 2013 | 368 | 0.080 |
Why?
|
Risk | 3 | 2010 | 9612 | 0.080 |
Why?
|
Developing Countries | 1 | 2022 | 2885 | 0.080 |
Why?
|
Europe | 1 | 2016 | 3423 | 0.080 |
Why?
|
Lactic Acid | 2 | 2024 | 1137 | 0.080 |
Why?
|
Scalp | 1 | 2012 | 389 | 0.080 |
Why?
|
Space Perception | 1 | 2012 | 465 | 0.080 |
Why?
|
Brain Chemistry | 1 | 2012 | 959 | 0.080 |
Why?
|
Mortality | 1 | 2020 | 2900 | 0.080 |
Why?
|
Suicide | 1 | 2020 | 1598 | 0.080 |
Why?
|
Online Systems | 1 | 2010 | 182 | 0.080 |
Why?
|
False Negative Reactions | 1 | 2010 | 573 | 0.080 |
Why?
|
Multimedia | 1 | 2009 | 75 | 0.080 |
Why?
|
Pituitary-Adrenal System | 1 | 2012 | 551 | 0.080 |
Why?
|
Benzothiazoles | 1 | 2010 | 247 | 0.080 |
Why?
|
Down Syndrome | 1 | 2017 | 901 | 0.080 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4287 | 0.080 |
Why?
|
Preoperative Care | 1 | 2017 | 2242 | 0.080 |
Why?
|
Statistics as Topic | 3 | 2015 | 2358 | 0.080 |
Why?
|
Perceptual Disorders | 1 | 2010 | 198 | 0.080 |
Why?
|
Postmenopause | 1 | 2017 | 2513 | 0.080 |
Why?
|
Neurons | 3 | 2020 | 9462 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6479 | 0.080 |
Why?
|
Cold Temperature | 1 | 2012 | 786 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2021 | 4027 | 0.080 |
Why?
|
Synapses | 2 | 2016 | 1769 | 0.080 |
Why?
|
Periodicity | 2 | 2008 | 347 | 0.070 |
Why?
|
Athletic Injuries | 3 | 2012 | 1216 | 0.070 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2012 | 700 | 0.070 |
Why?
|
Risk Assessment | 4 | 2017 | 23990 | 0.070 |
Why?
|
Visual Fields | 2 | 2012 | 1062 | 0.070 |
Why?
|
Health Status | 1 | 2021 | 4075 | 0.070 |
Why?
|
Electrophysiology | 2 | 2008 | 1262 | 0.070 |
Why?
|
Iran | 1 | 2010 | 738 | 0.070 |
Why?
|
Child, Preschool | 6 | 2016 | 42254 | 0.070 |
Why?
|
Saliva | 1 | 2012 | 827 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2691 | 0.070 |
Why?
|
Anxiety Disorders | 2 | 2022 | 2717 | 0.070 |
Why?
|
Angiography, Digital Subtraction | 2 | 2006 | 335 | 0.070 |
Why?
|
Anesthesia Recovery Period | 1 | 2008 | 155 | 0.070 |
Why?
|
Education, Medical, Continuing | 1 | 2012 | 823 | 0.070 |
Why?
|
Postoperative Care | 1 | 2014 | 1471 | 0.070 |
Why?
|
Phosphenes | 1 | 2007 | 41 | 0.070 |
Why?
|
Dopamine Agonists | 1 | 2010 | 352 | 0.070 |
Why?
|
Symbolism | 1 | 2007 | 34 | 0.070 |
Why?
|
Bibliometrics | 1 | 2011 | 352 | 0.070 |
Why?
|
Carotid Arteries | 1 | 2011 | 941 | 0.070 |
Why?
|
Biofeedback, Psychology | 1 | 2007 | 116 | 0.070 |
Why?
|
Databases, Factual | 2 | 2015 | 7956 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3110 | 0.070 |
Why?
|
Semantics | 2 | 2008 | 601 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2013 | 1474 | 0.070 |
Why?
|
Endpoint Determination | 1 | 2009 | 590 | 0.070 |
Why?
|
Limbic System | 1 | 2009 | 419 | 0.070 |
Why?
|
Benzodiazepines | 1 | 2012 | 1132 | 0.070 |
Why?
|
Dopamine | 1 | 2014 | 1605 | 0.070 |
Why?
|
Acute Disease | 2 | 2014 | 7238 | 0.070 |
Why?
|
Stereotaxic Techniques | 2 | 2008 | 555 | 0.070 |
Why?
|
Israel | 1 | 2008 | 726 | 0.070 |
Why?
|
Visceral Afferents | 1 | 2005 | 9 | 0.070 |
Why?
|
Perception | 1 | 2013 | 1197 | 0.070 |
Why?
|
Aging | 3 | 2023 | 8705 | 0.070 |
Why?
|
Arousal | 2 | 2015 | 1166 | 0.070 |
Why?
|
Radiation | 1 | 2005 | 49 | 0.070 |
Why?
|
International Cooperation | 2 | 2011 | 1422 | 0.070 |
Why?
|
Psychiatry | 2 | 2008 | 1692 | 0.070 |
Why?
|
Review Literature as Topic | 1 | 2008 | 347 | 0.070 |
Why?
|
Proteome | 1 | 2016 | 1862 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 2014 | 1199 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3204 | 0.060 |
Why?
|
Malnutrition | 1 | 2012 | 644 | 0.060 |
Why?
|
Drug Synergism | 1 | 2010 | 1755 | 0.060 |
Why?
|
Acetylcholine | 1 | 2007 | 629 | 0.060 |
Why?
|
Thoracic Vertebrae | 1 | 2010 | 596 | 0.060 |
Why?
|
Mathematics | 1 | 2007 | 707 | 0.060 |
Why?
|
Nerve Growth Factors | 1 | 2008 | 563 | 0.060 |
Why?
|
Brain Damage, Chronic | 1 | 2006 | 267 | 0.060 |
Why?
|
Speech Acoustics | 1 | 2006 | 154 | 0.060 |
Why?
|
Adaptation, Physiological | 2 | 2012 | 1301 | 0.060 |
Why?
|
Potassium Chloride | 1 | 2005 | 230 | 0.060 |
Why?
|
Overweight | 1 | 2016 | 2413 | 0.060 |
Why?
|
Amitriptyline | 1 | 2005 | 112 | 0.060 |
Why?
|
Professional-Patient Relations | 1 | 2010 | 726 | 0.060 |
Why?
|
Occupational Therapy | 1 | 2006 | 139 | 0.060 |
Why?
|
Dystonia | 1 | 2008 | 370 | 0.060 |
Why?
|
Life Change Events | 1 | 2009 | 952 | 0.060 |
Why?
|
Arteries | 1 | 2009 | 1124 | 0.060 |
Why?
|
Communicable Disease Control | 1 | 2011 | 846 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2023 | 2328 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2399 | 0.060 |
Why?
|
Torque | 1 | 2024 | 133 | 0.060 |
Why?
|
Carotid Stenosis | 1 | 2011 | 860 | 0.060 |
Why?
|
Cannabis | 1 | 2010 | 440 | 0.060 |
Why?
|
Voice Quality | 1 | 2006 | 226 | 0.060 |
Why?
|
Nutritional Status | 1 | 2012 | 1613 | 0.060 |
Why?
|
Mental Status Schedule | 1 | 2004 | 314 | 0.060 |
Why?
|
Chi-Square Distribution | 4 | 2013 | 3418 | 0.060 |
Why?
|
Athletic Performance | 1 | 2024 | 111 | 0.060 |
Why?
|
Neural Conduction | 1 | 2005 | 441 | 0.060 |
Why?
|
Dysarthria | 1 | 2003 | 58 | 0.060 |
Why?
|
Hypnosis | 2 | 2014 | 82 | 0.060 |
Why?
|
Neurofeedback | 2 | 2014 | 44 | 0.060 |
Why?
|
Weight-Bearing | 1 | 2006 | 532 | 0.050 |
Why?
|
Alexia, Pure | 1 | 2003 | 2 | 0.050 |
Why?
|
Patient Compliance | 1 | 2014 | 2690 | 0.050 |
Why?
|
Skin | 2 | 2016 | 4481 | 0.050 |
Why?
|
Hemifacial Spasm | 1 | 2003 | 24 | 0.050 |
Why?
|
Association Learning | 1 | 2005 | 221 | 0.050 |
Why?
|
Games, Experimental | 2 | 2014 | 32 | 0.050 |
Why?
|
Suicidal Ideation | 1 | 2013 | 1444 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2016 | 2163 | 0.050 |
Why?
|
United States | 3 | 2024 | 72339 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2009 | 1988 | 0.050 |
Why?
|
Linear Models | 4 | 2016 | 5869 | 0.050 |
Why?
|
Accidental Falls | 1 | 2011 | 1068 | 0.050 |
Why?
|
Mental Processes | 1 | 2004 | 244 | 0.050 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2003 | 42 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2005 | 432 | 0.050 |
Why?
|
Median Nerve | 1 | 2023 | 132 | 0.050 |
Why?
|
Logistic Models | 2 | 2008 | 13255 | 0.050 |
Why?
|
Treatment Failure | 1 | 2009 | 2642 | 0.050 |
Why?
|
Checklist | 1 | 2009 | 828 | 0.050 |
Why?
|
Educational Measurement | 1 | 2010 | 1254 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2016 | 80582 | 0.050 |
Why?
|
Visual Cortex | 1 | 2010 | 1107 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3268 | 0.050 |
Why?
|
Receptors, Opioid, mu | 1 | 2023 | 167 | 0.050 |
Why?
|
Osteoporosis | 1 | 2012 | 1605 | 0.050 |
Why?
|
Caribbean Region | 1 | 2023 | 191 | 0.050 |
Why?
|
Informed Consent | 1 | 2009 | 1008 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2220 | 0.050 |
Why?
|
Hospitalization | 1 | 2022 | 10718 | 0.050 |
Why?
|
Surgical Procedures, Operative | 1 | 2014 | 1923 | 0.050 |
Why?
|
Synaptic Transmission | 1 | 2008 | 1173 | 0.050 |
Why?
|
Nociceptors | 1 | 2006 | 461 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 21341 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 2 | 2006 | 1432 | 0.050 |
Why?
|
Auditory Cortex | 1 | 2006 | 363 | 0.050 |
Why?
|
Acoustic Stimulation | 1 | 2006 | 1235 | 0.050 |
Why?
|
Social Perception | 1 | 2005 | 433 | 0.050 |
Why?
|
Schizophrenic Psychology | 1 | 2009 | 1647 | 0.050 |
Why?
|
Anaphylaxis | 1 | 2009 | 757 | 0.050 |
Why?
|
Cerebral Infarction | 1 | 2006 | 983 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3322 | 0.050 |
Why?
|
Immunity | 1 | 2007 | 997 | 0.050 |
Why?
|
Radiometry | 1 | 2007 | 813 | 0.050 |
Why?
|
Deltaproteobacteria | 1 | 2021 | 8 | 0.050 |
Why?
|
Oscillometry | 1 | 2021 | 150 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11902 | 0.050 |
Why?
|
Biophysics | 2 | 2014 | 380 | 0.050 |
Why?
|
Head | 1 | 2007 | 924 | 0.050 |
Why?
|
Kindling, Neurologic | 1 | 2020 | 24 | 0.050 |
Why?
|
Meditation | 2 | 2014 | 251 | 0.050 |
Why?
|
Ischemic Attack, Transient | 1 | 2006 | 882 | 0.040 |
Why?
|
Oxyhemoglobins | 1 | 2021 | 211 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6485 | 0.040 |
Why?
|
Pentylenetetrazole | 1 | 2020 | 71 | 0.040 |
Why?
|
Convulsants | 1 | 2020 | 70 | 0.040 |
Why?
|
Interleukin-1alpha | 1 | 2020 | 86 | 0.040 |
Why?
|
Fingers | 1 | 2023 | 507 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2003 | 485 | 0.040 |
Why?
|
Rats, Long-Evans | 1 | 2020 | 383 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2012 | 2491 | 0.040 |
Why?
|
Students | 1 | 2010 | 1741 | 0.040 |
Why?
|
Body Temperature | 1 | 2023 | 782 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 10766 | 0.040 |
Why?
|
Diazepam | 1 | 2020 | 215 | 0.040 |
Why?
|
Receptor, trkB | 1 | 2020 | 124 | 0.040 |
Why?
|
Nerve Growth Factor | 1 | 2020 | 158 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1725 | 0.040 |
Why?
|
Vision Disorders | 1 | 2006 | 1088 | 0.040 |
Why?
|
Recurrence | 2 | 2009 | 8469 | 0.040 |
Why?
|
History, 20th Century | 3 | 2013 | 2769 | 0.040 |
Why?
|
Obesity | 2 | 2018 | 12938 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2319 | 0.040 |
Why?
|
Blood Pressure | 1 | 2014 | 8487 | 0.040 |
Why?
|
Noise | 1 | 2021 | 290 | 0.040 |
Why?
|
Sesquiterpenes | 1 | 2019 | 176 | 0.040 |
Why?
|
Neoplasms | 1 | 2007 | 22164 | 0.040 |
Why?
|
Anterior Cruciate Ligament | 2 | 2012 | 423 | 0.040 |
Why?
|
Alkaloids | 1 | 2019 | 192 | 0.040 |
Why?
|
Rats, Inbred WKY | 1 | 2018 | 151 | 0.040 |
Why?
|
Rats, Inbred SHR | 1 | 2018 | 186 | 0.040 |
Why?
|
Sulfur Compounds | 1 | 2017 | 32 | 0.040 |
Why?
|
Cell Death | 1 | 2023 | 1677 | 0.040 |
Why?
|
Cervical Vertebrae | 1 | 2004 | 981 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15262 | 0.040 |
Why?
|
Burns, Electric | 1 | 2017 | 40 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10548 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14664 | 0.030 |
Why?
|
Dementia | 1 | 2011 | 2686 | 0.030 |
Why?
|
History, 19th Century | 2 | 2010 | 720 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2023 | 15941 | 0.030 |
Why?
|
Muscle Spasticity | 1 | 2017 | 157 | 0.030 |
Why?
|
Muscle Tonus | 1 | 2016 | 82 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 14026 | 0.030 |
Why?
|
Genotype | 2 | 2022 | 13009 | 0.030 |
Why?
|
Prevalence | 2 | 2024 | 15717 | 0.030 |
Why?
|
Administration, Oral | 1 | 2004 | 4016 | 0.030 |
Why?
|
Breath Tests | 1 | 2017 | 298 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 413 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2008 | 3460 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2008 | 3576 | 0.030 |
Why?
|
Survival Analysis | 1 | 2009 | 10089 | 0.030 |
Why?
|
History, 21st Century | 2 | 2013 | 1567 | 0.030 |
Why?
|
Appetite Regulation | 1 | 2016 | 84 | 0.030 |
Why?
|
Apoptosis | 2 | 2023 | 9488 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 1967 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3407 | 0.030 |
Why?
|
Prognosis | 3 | 2017 | 29620 | 0.030 |
Why?
|
Autistic Disorder | 1 | 2005 | 1220 | 0.030 |
Why?
|
Alleles | 2 | 2019 | 6922 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 16979 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2011 | 8999 | 0.030 |
Why?
|
Social Control, Informal | 1 | 2014 | 44 | 0.030 |
Why?
|
Reward | 2 | 2014 | 971 | 0.030 |
Why?
|
Gyrus Cinguli | 2 | 2014 | 1115 | 0.030 |
Why?
|
Pupil | 1 | 2015 | 146 | 0.030 |
Why?
|
Rhode Island | 1 | 2014 | 351 | 0.030 |
Why?
|
Administration, Sublingual | 1 | 2013 | 58 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2003 | 2189 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1004 | 0.030 |
Why?
|
Body Weight | 2 | 2015 | 4618 | 0.030 |
Why?
|
Ovariectomy | 1 | 2015 | 614 | 0.030 |
Why?
|
Cerebellar Ataxia | 1 | 2014 | 150 | 0.030 |
Why?
|
Event-Related Potentials, P300 | 1 | 2014 | 149 | 0.030 |
Why?
|
Handwriting | 1 | 2012 | 26 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21012 | 0.030 |
Why?
|
Appetite | 1 | 2014 | 247 | 0.030 |
Why?
|
Sleep Deprivation | 1 | 2019 | 843 | 0.030 |
Why?
|
Freund's Adjuvant | 1 | 2012 | 149 | 0.030 |
Why?
|
Rotation | 1 | 2014 | 517 | 0.020 |
Why?
|
Gene Frequency | 1 | 2019 | 3647 | 0.020 |
Why?
|
Cell Cycle | 1 | 2020 | 2932 | 0.020 |
Why?
|
Cats | 1 | 2013 | 975 | 0.020 |
Why?
|
Radiography | 1 | 2003 | 6966 | 0.020 |
Why?
|
Auditory Perceptual Disorders | 1 | 2011 | 36 | 0.020 |
Why?
|
Central Nervous System Depressants | 1 | 2012 | 164 | 0.020 |
Why?
|
Eating | 1 | 2018 | 1538 | 0.020 |
Why?
|
Corticosterone | 1 | 2012 | 305 | 0.020 |
Why?
|
Psychological Tests | 1 | 2014 | 640 | 0.020 |
Why?
|
Tunica Media | 1 | 2011 | 112 | 0.020 |
Why?
|
Oxygen | 3 | 2010 | 4228 | 0.020 |
Why?
|
Observer Variation | 1 | 2017 | 2605 | 0.020 |
Why?
|
Probability | 1 | 2016 | 2478 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2013 | 352 | 0.020 |
Why?
|
Needles | 1 | 2014 | 451 | 0.020 |
Why?
|
Choline | 1 | 2012 | 515 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2014 | 546 | 0.020 |
Why?
|
Hypothalamus | 1 | 2016 | 999 | 0.020 |
Why?
|
Maze Learning | 1 | 2012 | 483 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2013 | 629 | 0.020 |
Why?
|
Brain Stem | 1 | 2015 | 858 | 0.020 |
Why?
|
Signal Detection, Psychological | 1 | 2010 | 84 | 0.020 |
Why?
|
Bone Nails | 1 | 2011 | 219 | 0.020 |
Why?
|
Wrist | 1 | 2011 | 227 | 0.020 |
Why?
|
Forearm | 1 | 2012 | 427 | 0.020 |
Why?
|
Bioethical Issues | 1 | 2010 | 120 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3684 | 0.020 |
Why?
|
Uncertainty | 1 | 2014 | 754 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2012 | 411 | 0.020 |
Why?
|
Speech Production Measurement | 1 | 2009 | 96 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2012 | 370 | 0.020 |
Why?
|
Acupuncture Therapy | 1 | 2014 | 486 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8542 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10498 | 0.020 |
Why?
|
Self Disclosure | 1 | 2010 | 249 | 0.020 |
Why?
|
Tunica Intima | 1 | 2011 | 458 | 0.020 |
Why?
|
Exercise Movement Techniques | 1 | 2009 | 10 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3702 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2014 | 710 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2013 | 857 | 0.020 |
Why?
|
Electric Impedance | 1 | 2013 | 756 | 0.020 |
Why?
|
Magnetoencephalography | 1 | 2012 | 636 | 0.020 |
Why?
|
Eye Movements | 1 | 2012 | 511 | 0.020 |
Why?
|
Coronary Disease | 1 | 2003 | 5919 | 0.020 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2008 | 22 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1336 | 0.020 |
Why?
|
Phenylcarbamates | 1 | 2007 | 38 | 0.020 |
Why?
|
Americas | 1 | 2008 | 111 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3810 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2008 | 26212 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2015 | 1060 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3580 | 0.020 |
Why?
|
Bone Screws | 1 | 2011 | 532 | 0.020 |
Why?
|
Neurosurgery | 1 | 2014 | 679 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2574 | 0.020 |
Why?
|
Health Surveys | 1 | 2017 | 4059 | 0.020 |
Why?
|
Endometriosis | 1 | 2015 | 869 | 0.020 |
Why?
|
Protons | 1 | 2012 | 1115 | 0.020 |
Why?
|
Darkness | 1 | 2007 | 158 | 0.020 |
Why?
|
Tectum Mesencephali | 1 | 2006 | 18 | 0.020 |
Why?
|
Sensory Deprivation | 1 | 2007 | 108 | 0.020 |
Why?
|
Exercise Test | 1 | 2014 | 2129 | 0.020 |
Why?
|
Infant | 1 | 2008 | 36205 | 0.020 |
Why?
|
Visual Pathways | 1 | 2010 | 551 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2014 | 1495 | 0.020 |
Why?
|
Expressed Emotion | 1 | 2006 | 92 | 0.020 |
Why?
|
Temperament | 1 | 2008 | 297 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 2007 | 242 | 0.020 |
Why?
|
Italy | 1 | 2008 | 843 | 0.020 |
Why?
|
Rheumatic Diseases | 1 | 2012 | 648 | 0.020 |
Why?
|
Ethics, Medical | 1 | 2010 | 783 | 0.020 |
Why?
|
Neuropsychology | 1 | 2006 | 107 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2019 | 3049 | 0.020 |
Why?
|
Mice | 1 | 2012 | 81509 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2007 | 490 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2011 | 1586 | 0.010 |
Why?
|
Weight Loss | 1 | 2016 | 2683 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8545 | 0.010 |
Why?
|
Drug Discovery | 1 | 2012 | 1051 | 0.010 |
Why?
|
Sleep, REM | 1 | 2007 | 594 | 0.010 |
Why?
|
Face | 1 | 2010 | 1026 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 2 | 2009 | 4063 | 0.010 |
Why?
|
Phonetics | 1 | 2005 | 198 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22168 | 0.010 |
Why?
|
Anomia | 1 | 2003 | 13 | 0.010 |
Why?
|
Atrophy | 1 | 2008 | 1633 | 0.010 |
Why?
|
Diagnostic Imaging | 2 | 2008 | 3530 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3724 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2005 | 554 | 0.010 |
Why?
|
Neuromuscular Agents | 1 | 2003 | 147 | 0.010 |
Why?
|
Botulinum Toxins | 1 | 2003 | 189 | 0.010 |
Why?
|
Blindness | 1 | 2005 | 584 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12456 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11073 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5970 | 0.010 |
Why?
|
Anticoagulants | 1 | 2014 | 4813 | 0.010 |
Why?
|
Amygdala | 1 | 2006 | 1353 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2007 | 1958 | 0.010 |
Why?
|
Decompression, Surgical | 1 | 2003 | 608 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13637 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2006 | 2881 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15498 | 0.000 |
Why?
|